Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|April 29, 2021
Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma-A National Retrospective StudyMarek Ussowicz, Aleksandra Wieczorek, Agnieszka Dłużniewska, et al.
Endokrynologia Polska|September 29, 2006
[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]Aleksandra Kukulska, Jolanta Krajewska, Józef Roskosz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2007
Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancerDaria Handkiewicz-Junak, Jan Wloch, Jozef Roskosz, et al.
Endokrynologia Polska|September 29, 2006
[Completion total thyroidectomy in children with differentiated thyroid cancer]Daria Handkiewicz-Junak, Jan Włoch, Agnieszka Czarniecka, et al.
NPJ Breast Cancer|May 10, 2026
Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancerMarcin Kubeczko, Anna Polakiewicz-Gilowska, Andrea d'Amico, et al.
Archives of Medical Science : AMS|September 26, 2022
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomesAleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska, et al.
Frontiers in Endocrinology|September 23, 2021
Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015Agnieszka Czarniecka, Marcin Zeman, Grzegorz Wozniak, et al.
Thyroid : Official Journal of the American Thyroid Association|May 14, 2026
TSH Stimulation Methods Are Associated With Comparable Outcomes in Radioiodine-Avid Metastatic Differentiated Thyroid Cancer: Single Center Retrospective Observational StudyAleksandra Ledwon, Ewa Paliczka-Cieślik, Aleksandra Kropińska, et al.
Endokrynologia Polska|November 5, 2010
Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary resultsAgnieszka Czarniecka, Dagmara Rusinek, Ewa Stobiecka, et al.
Thyroid Research|November 3, 2010
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCiAleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska-Suwińska, et al.
Pageof 8